These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22558072)

  • 1. Targeted delivery of chemotherapy agents using a liver cancer-specific aptamer.
    Meng L; Yang L; Zhao X; Zhang L; Zhu H; Liu C; Tan W
    PLoS One; 2012; 7(4):e33434. PubMed ID: 22558072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.
    Huang YF; Shangguan D; Liu H; Phillips JA; Zhang X; Chen Y; Tan W
    Chembiochem; 2009 Mar; 10(5):862-8. PubMed ID: 19253922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery.
    Leach JC; Wang A; Ye K; Jin S
    Int J Mol Sci; 2016 Mar; 17(3):380. PubMed ID: 26985893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Proliferative Effect of Doxorubicin-Loaded AS1411 Aptamer on Colorectal Cancer Cell.
    Lohlamoh W; Soontornworajit B; Rotkrua P
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2209-219. PubMed ID: 34319045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced targeting of 3D pancreatic cancer spheroids by aptamer-conjugated polymeric micelles with deep tumor penetration.
    Tian L; Pei R; Zhong L; Ji Y; Zhou D; Zhou S
    Eur J Pharmacol; 2021 Mar; 894():173814. PubMed ID: 33352182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Doxorubicin with Gemcitabine-Incorporated G-Quadruplex Aptamer Showed Synergistic and Selective Anticancer Effect in Breast Cancer Cells.
    Joshi M; Choi JS; Park JW; Doh KO
    J Microbiol Biotechnol; 2019 Nov; 29(11):1799-1805. PubMed ID: 31546295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of aptamer 5TR1 in triple negative breast cancer target therapy.
    Luo S; Wang S; Luo N; Chen F; Hu C; Zhang K
    J Cell Biochem; 2018 Jan; 119(1):896-908. PubMed ID: 28671278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo.
    Fang Y; Yang W; Cheng L; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2017 Dec; 64():323-333. PubMed ID: 29030307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells.
    Zhou G; Da Won Bae S; Nguyen R; Huo X; Han S; Zhang Z; Hebbard L; Duan W; Eslam M; Liddle C; Yuen L; Lam V; Qiao L; George J
    Cancer Lett; 2021 Mar; 501():124-132. PubMed ID: 33352247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tracing the Therapeutic Process of Targeted Aptamer/Drug Conjugate on Cancer Cells by Surface-Enhanced Raman Scattering Spectroscopy.
    Deng R; Qu H; Liang L; Zhang J; Zhang B; Huang D; Xu S; Liang C; Xu W
    Anal Chem; 2017 Mar; 89(5):2844-2851. PubMed ID: 28192929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Bivalent Aptamer-DNA Carrier-Doxorubicin Conjugates for Targeted Killing of Esophageal Squamous Cell Carcinoma Cells.
    Zhang T; Yin K; Niu X; Bai X; Wang Z; Ji M; Yuan B
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
    Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
    Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Covalently conjugated DNA aptamer with doxorubicin as in vitro model for effective targeted drug delivery to human glioblastoma tumor cells].
    Sliman YA; Samoylenkova NS; Antipova OM; Brylev VA; Veryutin DA; Sapozhnikova KA; Alekseeva AI; Pronin IN; Kopylov AM; Pavlova GV
    Zh Vopr Neirokhir Im N N Burdenko; 2024; 88(1):48-55. PubMed ID: 38334730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target-specific delivery of doxorubicin to human glioblastoma cell line via ssDNA aptamer.
    Bayrac AT; Akca OE; Eyidogan FI; Oktem HA
    J Biosci; 2018 Mar; 43(1):97-104. PubMed ID: 29485118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer.
    Subramanian N; Raghunathan V; Kanwar JR; Kanwar RK; Elchuri SV; Khetan V; Krishnakumar S
    Mol Vis; 2012; 18():2783-95. PubMed ID: 23213278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivalent Aptamer-RNA Conjugates for Simple and Efficient Delivery of Doxorubicin/siRNA into Multidrug-Resistant Cells.
    Jeong H; Lee SH; Hwang Y; Yoo H; Jung H; Kim SH; Mok H
    Macromol Biosci; 2017 Apr; 17(4):. PubMed ID: 27863037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer.
    Bagalkot V; Zhang L; Levy-Nissenbaum E; Jon S; Kantoff PW; Langer R; Farokhzad OC
    Nano Lett; 2007 Oct; 7(10):3065-70. PubMed ID: 17854227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced growth inhibition of prostate cancer in vitro and in vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system.
    Jing P; Cao S; Xiao S; Zhang X; Ke S; Ke F; Yu X; Wang L; Wang S; Luo Y; Zhong Z
    Cancer Lett; 2016 Dec; 383(2):230-242. PubMed ID: 27721020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivo.
    Ma Z; He H; Sun F; Xu Y; Huang X; Ma Y; Zhao H; Wang Y; Wang M; Zhang J
    J Cancer Res Clin Oncol; 2017 Oct; 143(10):1929-1940. PubMed ID: 28536738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.